Facile and Cost-Effective Route for the Synthesis of Simmerafil

Author:

Odilov Abdullajon12,Liu Yin12,Hu Tianwen23,Jiang Xiangrui12ORCID,Suo Jin1,Tian Guanghui4,Yang Feipu1ORCID,Shen Jingshan12ORCID

Affiliation:

1. CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, P. R. China

2. University of Chinese Academy of Sciences, Beijing 100049, P. R. China

3. Key Laboratory of Plant Resources and Chemistry in Arid Regions, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, Xinjiang, P. R. China

4. Vigonvita Life Science Co., Ltd., Suzhou, Jiangsu 215123, P. R. China

Funder

Ministry of Science and Technology of the People's Republic of China

National Science and Technology Major Project

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Reference13 articles.

1. Pharmacokinetics-Driven Optimization of 4(3H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension

2. Targeted Drugs for Treatment of Pulmonary Arterial Hypertension: Past, Present, and Future Perspectives

3. Liu, Z.; Li, J. F.; Yang, X. J.; Wang, Z.; Zhang, J. F.; Zhu, Y.; Tian, G. H.; Jin, Q.; Shen, J. K.; Zhu, W. L.; Phenyl pyrimidone compounds, pharmaceutical compositions, preparation methods and uses thereof. EP2383262A1, 2011.

4. Shen, J. S.; He, Y.; Chen, W. M.; Li, J. F.; Tian, G. H.; Gong, X. D.; Wang, Z.; Zhang, R. X.; Liu, Y. J.; Jiang, H. L. Salt and polymorph of benzopyrimidinone compound and pharmaceutical composition and use thereof. US2020,140,415A1, 2020.

5. Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [11C]TPN171 as a new potential PET heart imaging agent

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3